NRX Pharmaceuticals, Inc. — Director's Dealing 2021

Nov 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NRX Pharmaceuticals, Inc. (NRXP)
CIK: 0001719406
Period of Report: 2021-07-16

Reporting Person: Javitt Daniel C. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-16	Common Stock	G	434594	—	Disposed	13537270	Indirect
2021-07-16	Common Stock	G	434594	—	Disposed	13102676	Indirect

Footnotes

F1: Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers.

F2: Held by Glytech, LLC of which the Reporting Person is the sole owner.